Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voclosporin in active lupus nephritis
CTR20234324Phase 3Active
- Sponsor
- Qilu Pharmaceutical
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of voclosporin in lupus nephritis (LN), sponsored by Qilu Pharmaceutical. Started Mar 2024; status: active.
02
Drugs
voclosporin
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on CTR20234324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20234324.